PSYCH OpenIR  > 中国科学院心理健康重点实验室
Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor
Bian, Li-hua1; Yao, Zi-wei1; Zhao, Cheng-bowen1; Li, Qiu-yu1; Shi, Jin-li1; Guo, Jian-you2
通讯作者邮箱shijl@vip.sina.com (jin-li shi) ; bioyou@126.com (jian-you guo)
心理所单位排序2
摘要

Nardostachyos Radix et Rhizoma (nardostachys) is the root and rhizome of Nardostachys jatamansi DC. Recent studies have shown that nardostachys may exert an anti-PD effect. In this study, the UHPLC-LTQ-Orbitrap-MS method was used to analyze the brain components of nardostachys in rats. Based on the results of UHPLC-LTQ-Orbitrap-MS analysis, nardosinone was identified to be the most effective anti-PD compound in nardostachys. To further verify this inference, a mouse PD model was established and the effect of nardosinone on PD mice was determined using classic behavioral tests. The results showed that nardosinone was indeed effective for relieving PD symptoms in mice. Moreover, network pharmacology analysis was used to elucidate the mechanism underlying the anti-PD effect of nardosinone. Dopamine receptor D2 (DRD2) was identified as the key target of nardosinone-PD interaction network, which was further verified by molecular docking and Western blotting. The results demonstrated that nardosinone and DRD2 could interact with each other. Furthermore, the expression level of DRD2 was decreased in the brain tissue of PD mice, and nardosinone could restore its expression to a certain extent. In conclusion, our findings suggest that nardosinone may reduce the motor and cognitive symptoms in the animal PD model by regulating DRD2 expression.

2021-08-14
语种英语
DOI10.1155/2021/6686965
发表期刊EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
ISSN1741-427X
卷号2021页码:14
期刊论文类型实证研究
收录类别SCI
资助项目National Natural Science Foundation of China[81673560]
出版者HINDAWI LTD
WOS关键词NARDOSTACHYS-JATAMANSI ; NETWORK PHARMACOLOGY ; POLYMORPHISMS ; EXPOSURE ; DRD2 ; ASSOCIATION
WOS研究方向Integrative & Complementary Medicine
WOS类目Integrative & Complementary Medicine
WOS记录号WOS:000687476200001
WOS分区Q2
资助机构National Natural Science Foundation of China
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.psych.ac.cn/handle/311026/40113
专题中国科学院心理健康重点实验室
通讯作者Shi, Jin-li; Guo, Jian-you
作者单位1.Beijing Univ Chinese Med, Sch Chinese Mat Med, 11A North Third Ring East Rd, Beijing 100029, Peoples R China
2.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, 4A Datun Rd, Beijing 100101, Peoples R China
推荐引用方式
GB/T 7714
Bian, Li-hua,Yao, Zi-wei,Zhao, Cheng-bowen,et al. Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2021,2021:14.
APA Bian, Li-hua,Yao, Zi-wei,Zhao, Cheng-bowen,Li, Qiu-yu,Shi, Jin-li,&Guo, Jian-you.(2021).Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2021,14.
MLA Bian, Li-hua,et al."Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor".EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2021(2021):14.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Nardosinone Alleviat(7479KB)期刊论文出版稿限制开放CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bian, Li-hua]的文章
[Yao, Zi-wei]的文章
[Zhao, Cheng-bowen]的文章
百度学术
百度学术中相似的文章
[Bian, Li-hua]的文章
[Yao, Zi-wei]的文章
[Zhao, Cheng-bowen]的文章
必应学术
必应学术中相似的文章
[Bian, Li-hua]的文章
[Yao, Zi-wei]的文章
[Zhao, Cheng-bowen]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。